表紙:フォンウィルブランド病(VWD)治療薬の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要プレイヤー、競争戦略および予測、2023年から2031年まで
市場調査レポート
商品コード
1283948

フォンウィルブランド病(VWD)治療薬の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要プレイヤー、競争戦略および予測、2023年から2031年まで

Von Willebrand Disease (VWD) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

出版日: | 発行: Acute Market Reports | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
フォンウィルブランド病(VWD)治療薬の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要プレイヤー、競争戦略および予測、2023年から2031年まで
出版日: 2023年05月09日
発行: Acute Market Reports
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

フォンウィルブランド病(VWD)治療薬の市場は、2031年までに5.5%の成長が見込まれます。世界血友病連盟(WFH)によると、フォンウィルブランド病(VWD)は出血性疾患の中で最も一般的なタイプです。VWDの方は、血液中のフォンウィルブランド因子(VWF)と呼ばれる出血を抑える働きをするタンパク質に問題があります。血管が傷ついて出血すると、VWFは血小板と呼ばれる血液中の細胞がかみ合い、血栓を形成して出血を止めるのを助ける。専門家によると、世界人口の約1%がVWDに罹患していると言われていますが、症状が非常に軽いため、この疾患について知っている患者さんはごくわずかです。調査によると、10人中9人が診断を受けていないことが判明しています。フォンウィルブランド病の治療市場は、フォンウィルブランド病の種類によって、1型、2型、3型に分類されます。フォンウィルブランド病に対して使用される治療法の種類は、デスモプレシン(DDAVP)、ホルモン補充療法、避妊薬、抗線溶薬または血栓安定薬、フィブリンシーラントです。

最近、TevaとEagle PharmaceuticalsのBendeka(ベンダムスチン)製品が、慢性リンパ性白血病とB細胞性非ホジキンリンパ腫を対象に、より短時間かつ少量の点滴で投与できる新しい製剤としてFDAから承認されました。Tevaは2月にEagleと締結した契約でBendekaに関する米国の商業化権を持っており、2016年の第1四半期に本療法を発売する予定です。

フォンウィルブランド病の成長の主な要因は、フォンウィルブランド病に関連する社会的認知度の向上であり、北米と欧州における診断率の上昇を後押ししています。北米は、フォンウィルブランド病治療の最大市場として観察され、次いで欧州となりました。アジア太平洋は、2016年から2022年の予測期間中に最も速いCAGRで成長すると予測されました。アジア太平洋地域のフォンウィルブランド病治療市場の成長を支える主な要因は、希少疾患に関連する意識の高まり、ヘルスケアインフラの開拓、高い可処分所得、希少遺伝病に対する新規治療に対する政府の支援です。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象読者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者別レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

  • 市場スナップショット:世界のフォンウィルブランド病(VWD)治療薬の市場
  • 疾患別の世界のフォンウィルブランド病(VWD)治療薬の市場 2022
  • 世界のフォンウィルブランド病(VWD)治療薬の市場:(医薬品別) 2022
  • 投与経路別の世界のフォンウィルブランド病(VWD)治療薬の市場 2022
  • 地域別の世界のフォンウィルブランド病(VWD)治療薬の市場 2022
  • 魅力的な投資提案:地域別 2022

第3章 フォンウィルブランド病(VWD)治療薬の市場:競合分析

  • 主要ベンダーの市場での位置付け
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析:2022 vs 2031

第4章 フォンウィルブランド病(VWD)治療薬の市場:マクロ分析と市場力学

  • イントロダクション
  • 世界のフォンウィルブランド病(VWD)治療薬の市場価値 2021-2031
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 フォンウィルブランド病(VWD)治療薬の疾患別市場 2021-2031

  • 市場概要
  • 成長・収益分析:2022 vs 2031
  • 市場セグメンテーション
    • 1型フォン・ヴィレブランド病
    • 2型フォン・ヴィレブランド病
    • 3型フォン・ヴィレブランド病
    • 後天性フォンヴィレブランド病

第6章 フォンウィルブランド病(VWD)治療薬の医薬品別市場 2021-2031

  • 市場概要
  • 成長・収益分析:2022 vs 2031
  • 市場セグメンテーション
    • デスモプレシン
    • 血栓安定化薬
    • 補充療法
    • 避妊薬
    • その他

第7章 フォンウィルブランド病(VWD)治療薬の投与経路別市場 2021-2031

  • 市場概要
  • 成長・収益分析:2022 vs 2031
  • 市場セグメンテーション
    • オーラル
    • 注入
    • その他

第8章 北米フォンウィルブランド病(VWD)治療薬の市場 2021-2031

  • 市場概要
  • フォンウィルブランド病(VWD)治療薬の疾患別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の医薬品別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の投与経路別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の地域別市場 2021-2031
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第9章 英国および欧州連合フォンウィルブランド病(VWD)治療薬の市場 2021-2031

  • 市場概要
  • フォンウィルブランド病(VWD)治療薬の疾患別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の医薬品別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の投与経路別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の地域別市場 2021-2031
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第10章 アジア太平洋フォンウィルブランド病(VWD)治療薬の市場 2021-2031

  • 市場概要
  • フォンウィルブランド病(VWD)治療薬の疾患別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の医薬品別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の投与経路別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の地域別市場 2021-2031
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第11章 ラテンアメリカフォンウィルブランド病(VWD)治療薬の市場 2021-2031

  • 市場概要
  • フォンウィルブランド病(VWD)治療薬の疾患別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の医薬品別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の投与経路別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の地域別市場 2021-2031
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第12章 中東およびアフリカフォンウィルブランド病(VWD)治療薬の市場 2021-2031

  • 市場概要
  • フォンウィルブランド病(VWD)治療薬の疾患別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の医薬品別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の投与経路別市場 2021-2031
  • フォンウィルブランド病(VWD)治療薬の地域別市場 2021-2031
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第13章 企業プロファイル

  • Octapharma AG
  • Grifols S.A.
  • Shire plc
  • Bayer AG
  • CSL Behring
  • Pfizer Inc.
  • Akorn Inc.
  • Ferring B.V.
  • その他の注目選手
図表

List of Tables

  • TABLE 1 Global Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 2 Global Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 3 Global Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 4 North America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 5 North America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 6 North America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 7 U.S. Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 8 U.S. Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 9 U.S. Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 10 Canada Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 11 Canada Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 12 Canada Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 19 UK Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 20 UK Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 21 UK Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 22 Germany Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 23 Germany Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 24 Germany Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 25 Spain Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 26 Spain Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 27 Spain Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 28 Italy Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 29 Italy Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 30 Italy Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 31 France Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 32 France Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 33 France Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 37 Asia Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 38 Asia Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 39 Asia Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 40 China Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 41 China Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 42 China Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 43 Japan Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 44 Japan Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 45 Japan Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 46 India Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 47 India Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 48 India Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 49 Australia Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 50 Australia Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 51 Australia Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 52 South Korea Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 53 South Korea Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 54 South Korea Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 55 Latin America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 56 Latin America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 57 Latin America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 58 Brazil Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 59 Brazil Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 60 Brazil Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 61 Mexico Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 62 Mexico Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 63 Mexico Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 70 GCC Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 71 GCC Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 72 GCC Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 73 Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 74 Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 75 Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Von Willebrand Disease (VWD) Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Von Willebrand Disease (VWD) Treatment Market: Quality Assurance
  • FIG. 5 Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022
  • FIG. 6 Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022
  • FIG. 7 Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022
  • FIG. 8 Global Von Willebrand Disease (VWD) Treatment Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Von Willebrand Disease (VWD) Treatment Market, 2022
  • FIG. 10 Market Positioning of Key Von Willebrand Disease (VWD) Treatment Market Players, 2022
  • FIG. 11 Global Von Willebrand Disease (VWD) Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 12 Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022 Vs 2031, %
  • FIG. 13 Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022 Vs 2031, %
  • FIG. 14 Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022 Vs 2031, %
  • FIG. 15 U.S. Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 22 France Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 24 China Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 26 India Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
目次
Product Code: 136862-05-23

Von Willebrand Disease (VWD) Treatment Market is Expected to Grow at 5.5% by 2031. According to World Federation of Hemophilia (WFH), von Willebrand disease (VWD) is the most common type of bleeding disorder. People with VWD have a problem with a protein in their blood called von Willebrand factor (VWF) that helps control bleeding. When a blood vessel is injured and bleeding occurs, VWF helps cells in the blood, called platelets, mesh together and form a clot to stop the bleeding. According to market experts, around 1% of the world's population suffers from VWD, but due to presence of very mild symptoms only a few number of patients are aware about the condition. Research has shown that as many as 9 out of 10 people with VWD have not been diagnosed. On the basis of type of VWD, von Willebrand disease treatment market can be segmented as Type 1 VWD, Type 2 VWD and Type 3 VWD. The types of therapeutic treatments used against von Willebrand disease are Desmopressin (DDAVP), hormone replacement therapy, contraceptives, anti-fibrinolytic or clot-stabilizing drugs, and fibrin sealants.

Recently, the FDA has approved Bendeka (bendamustine) product of Teva and Eagle Pharmaceuticals, a novel drug formulation that can be administered via a shorter, lower-volume infusion - for chronic lymphocytic leukaemia and B-cell non-Hodgkin's lymphoma.It was observed that Teva received US commercialisation rights to Bendeka under a deal with Eagle signed in February, and plans to launch the therapy during the first quarter of 2016.

The key factor responsible for growth of von Willebrand disease is increasing public awareness related to VWD which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for von Willebrand disease treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period 2016 to 2022. The key factors assisting the growth of Asia Pacific von Willebrand disease treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.

Key Players Identified for von Willebrand disease (VWD) Treatment Market Include but are Not Limited to:

Octapharma AG, Crifols, S.A., Shire plc, Bayer AG, CSL Behring, Pfizer, Inc., Akorn, Inc., Ferring B.V. Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Von Willebrand Disease (VWD) Treatment market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Von Willebrand Disease (VWD) Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Disease Type

  • Type 1 von Willebrand Disease
  • Type 2 von Willebrand Disease
  • Type 3 von Willebrand Disease
  • Acquired von Willebrand Disease

Drug

  • Desmopressin
  • Clot-stabilizing Medications
  • Replacement Therapies
  • Contraceptives
  • Others

Route of Administration

  • Oral
  • Injection
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Von Willebrand Disease (VWD) Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Von Willebrand Disease (VWD) Treatment market?
  • Which is the largest regional market for Von Willebrand Disease (VWD) Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Von Willebrand Disease (VWD) Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Von Willebrand Disease (VWD) Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Von Willebrand Disease (VWD) Treatment Market
  • 2.2. Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022 (US$ Million)
  • 2.3. Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022 (US$ Million)
  • 2.4. Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022 (US$ Million)
  • 2.5. Global Von Willebrand Disease (VWD) Treatment Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Von Willebrand Disease (VWD) Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Von Willebrand Disease (VWD) Treatment Market Vendors
  • 3.2. Strategies Adopted by Von Willebrand Disease (VWD) Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Von Willebrand Disease (VWD) Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Von Willebrand Disease (VWD) Treatment Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Type 1 von Willebrand Disease
    • 5.3.2. Type 2 von Willebrand Disease
    • 5.3.3. Type 3 von Willebrand Disease
    • 5.3.4. Acquired von Willebrand Disease

6. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Desmopressin
    • 6.3.2. Clot-stabilizing Medications
    • 6.3.3. Replacement Therapies
    • 6.3.4. Contraceptives
    • 6.3.5. Others

7. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Oral
    • 7.3.2. Injection
    • 7.3.3. Others

8. North America Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 8.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 8.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 8.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

9. UK and European Union Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 9.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 9.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 9.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

10. Asia Pacific Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 10.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 10.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 10.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

11. Latin America Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 11.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 11.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 11.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

12. Middle East and Africa Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 12.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 12.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 12.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Octapharma AG
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Grifols, S.A.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Shire plc
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Bayer AG
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. CSL Behring
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Pfizer, Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Akorn, Inc.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Ferring B.V.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Other Notable Players
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives